MedWatch

Danish biotech company receives millions from US based capital fund

A new Danish biotech company has secured millions in a funding round led by the reputable US based capital fund Sofinnova Ventures, joined by Novo Seeds and Lundbeck Fond Emerge. Now, it goes for phase II and an initial public offering (IPO).

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

FDA vil lette vejen til markedet for medicin mod Alzheimers

De amerikanske lægemiddelmyndigheder vil lempe kravene til godkendelse af lægemidler mod Alzheimers, fordi forskning viser, at sygdommen indtræder tidligere end hidtil antaget. Lægemiddeludviklingen og godkendelse heraf derfor skal tilpasses derefter, mener FDA-boss Scott Gottlieb.

Related articles